Ivermectin ineffective in preventing severe Covid-19, finds Malaysian study


The researchers said their findings do not support the use of ivermectin for patients with COVID-19.

KUALA LUMPUR: (Reuters) Malaysian researchers found that treatment with the anti-parasite drug Ivermectin did not prevent patients with Covid-19 from becoming severely ill in a randomised clinical trial published in the Jama Internal Medicine journal on Friday.

The researchers said their findings do not support the use of Ivermectin for patients with Covid-19.

5.5 PAYDAY OFFER: 35% OFF Digital Access

Monthly Plan

RM 13.90/month

RM 9.04/month

Billed as RM 9.04 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.02/month

Billed as RM 96.20 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Ivermectin , Malaysia , researchers , Covid-19 ,

Next In Nation

Fix Pasir Gudang hospital staffing, equipment issues now, says Johor Regent
Exclude public hospitals from govt spending cuts, says MMA
Sabah rep urges review of budget cuts
James Chai continues giving statement to MACC for third day
Health Ministry: Unlicensed blood testing services risk RM500,000 fine, jail
Negeri Sembilan govt still stable despite Umno pullback, says Loke
Sabah minister outlines healthcare upgrades
AirTrunk to invest additional RM12bil in Malaysia this year
Decision on prosecution case against Ebit Lew this afternoon
Johor Regent repeats call for 25% tax revenue return

Others Also Read